Genprex to Present at Upcoming September Investor Conference

/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...

Related Keywords

Texas ,United States , ,Drug Administration ,Exchange Commission ,Company Website ,Genprex Inc ,Linkedin ,Facebook ,Twitter ,Highlight Company ,Gene Therapies ,Chief Financial Officer ,Ryan Confer ,Annual Global Investment ,Chief Financial ,Investor Relations ,Nanoparticle Delivery System ,Fast Track Designation ,Language Concerning Forward Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Genprex ,Nc ,